Lupin’s Humrahi Diabetes Support Program Expands to Include Heart Health – Lupin
Mumbai, November 18, 2024: Global pharma major Lupin Limited (Lupin) announced the re-launch of Humrahi at the Research Society for...
Mumbai, November 18, 2024: Global pharma major Lupin Limited (Lupin) announced the re-launch of Humrahi at the Research Society for...
Diabetes is one of the most common medical conditions among people in the United States. It also impacts us close...
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the...
NEW YORK, Jan. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential...
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same...
Recent findings from a 12-week prospective study have illuminated the potential of high-dose vitamin D3 as a strategic tool for...